San Diego-based Viking Therapeutics marked itself as a serious competitor during the weight loss drug industry in February right after revealing promising data from a mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As well as in March the co